542 related articles for article (PubMed ID: 34424267)
1. The early interferon catches the SARS-CoV-2.
Decker T
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34424267
[TBL] [Abstract][Full Text] [Related]
2. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
Kedl RM
J Exp Med; 2021 May; 218(5):. PubMed ID: 33861846
[TBL] [Abstract][Full Text] [Related]
3. Lasting memories of SARS-CoV-2 infection.
Poon MML; Farber DL
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33739364
[TBL] [Abstract][Full Text] [Related]
4. mSphere of Influence: Interferon Ultra Is a Means To Fight Viral Disease.
Bamford CGG
mSphere; 2020 Mar; 5(2):. PubMed ID: 32213622
[TBL] [Abstract][Full Text] [Related]
5. Clash of the titans: interferons and SARS-CoV-2.
Jouvenet N; Goujon C; Banerjee A
Trends Immunol; 2021 Dec; 42(12):1069-1072. PubMed ID: 34742657
[TBL] [Abstract][Full Text] [Related]
6. Breathe-Your immune system is counting on it.
McCarty NA
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33724301
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of impairment of interferon production by SARS-CoV-2.
Hoang HD; Naeli P; Alain T; Jafarnejad SM
Biochem Soc Trans; 2023 Jun; 51(3):1047-1056. PubMed ID: 37199495
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
[TBL] [Abstract][Full Text] [Related]
9. Not just a research method: If used with caution, can job-exposure matrices be a useful tool in the practice of occupational medicine and public health?
Fadel M; Evanoff BA; Andersen JH; d'Errico A; Dale AM; Leclerc A; Descatha A
Scand J Work Environ Health; 2020 Sep; 46(5):552-553. PubMed ID: 32367143
[TBL] [Abstract][Full Text] [Related]
10. Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2.
Li M
Cell Host Microbe; 2023 Sep; 31(9):1417-1419. PubMed ID: 37708846
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
12. Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic.
Meyts I
J Exp Med; 2022 Jun; 219(6):. PubMed ID: 35486090
[TBL] [Abstract][Full Text] [Related]
13. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
Gil M; Ramil F; AgÍs JA
Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
[TBL] [Abstract][Full Text] [Related]
14. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity and interferon in SARS-CoV-2 infection outcome.
Savan R; Gale M
Immunity; 2023 Jul; 56(7):1443-1450. PubMed ID: 37437537
[TBL] [Abstract][Full Text] [Related]
16. Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children.
Magalhães VG; Lukassen S; Drechsler M; Loske J; Burkart SS; Wüst S; Jacobsen EM; Röhmel J; Mall MA; Debatin KM; Eils R; Autenrieth S; Janda A; Lehmann I; Binder M
EMBO Rep; 2023 Dec; 24(12):e57912. PubMed ID: 37818799
[TBL] [Abstract][Full Text] [Related]
17. Roles of Type I and III Interferons in COVID-19.
Choi H; Shin EC
Yonsei Med J; 2021 May; 62(5):381-390. PubMed ID: 33908208
[TBL] [Abstract][Full Text] [Related]
18. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
